Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients
Clinical trial NCT05973344 · RECRUITING
Trial details
- NCT number
- NCT05973344
- Sponsor
- University Hospital, Brest
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-09
- Primary completion
- 2030-02-09
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.